Juice Authority said:
Can anyone accurately answer this question:
Does taking Nolva increase sperm count and production in males?
Juice...according to the studies I have investigated, there is some controversy. However there is a large body of evidence supporting the fact that tamoxifen can be used for male infertility in males with normogonadotropic oligozoospermia as well as idiopathic and other types of hypogonadotropic oligozoospermia.
Keep in mind that even if sperm count and concentrations may increase, sperm motility is a major determinant of pregnancy outcome.
Tamoxifen treatment in male infertility. I. Effect on spermatozoa.
Kotoulas IG, Cardamakis E, Michopoulos J, Mitropoulos D, Dounis A.
Department of Gynecology, General Hospital of Athens, Greece.
OBJECTIVE: To evaluate the effects of tamoxifen treatment on sperm density, motility, vitality, and morphology. DESIGN: Placebo-controlled, randomized study. SETTING: Outpatient department. INTERVENTIONS: Patients were assigned to two comparable groups: group A (n = 122) was treated with 10 mg tamoxifen twice daily for a period of 3 months and group B (n = 117) was given placebo for the same period of time, following a previously randomized design. MAIN OUTCOME MEASURES: In every patient sperm density, motility, viability, and morphology were evaluated 3 months after cessation of treatment. RESULTS:
Mean sperm density in group A improved significantly with a more pronounced improvement in severe oligozoospermic men. Sperm density was found significantly improved compared with group B. Dead spermatozoa in group A significantly decreased after tamoxifen treatment and were also found significantly decreased compared with group B. CONCLUSION: It is concluded that
tamoxifen exerts a beneficial effect on sperm density and number of live spermatozoa but it has no substantial effect in sperm motility and morphology.
Hormonal changes in tamoxifen treated men with idiopathic oligozoospermia.
Hampl R, Heresova J, Lachman M, Sulcova J, Starka L.
Research Institute of Endocrinology, Prague/Czechoslovakia.
Three months of tamoxifen treatment of 43 men with idiopathic oligozoospermia, out of which 20 completed the study,
resulted in a significant enhancement of sperm motility, but the improvement of sperm parameters was in no relation to the FSH response to short time tamoxifen treatment. There was a significant increase of testosterone, estradiol, LH, FSH, SHBG, 17 alpha-hydroxy-progesterone and also of 11 beta-hydroxyandrostenedione, an androgen of exclusively adrenal origin, during the treatment and (with the exception of the latter), on the first week after discontinuation of the therapy. Significantly elevated testosterone and SHBG concentrations were retained still 9 weeks after finishing of the therapy. The results confirm that
tamoxifen treatment provides conditions more favourable for conception and demonstrate that also adrenal steroidogenesis is positively influenced by this antiestrogen.
Improvement in semen quality in infertile males after treatment with tamoxifen.
Lewis-Jones DI, Lynch RV, Machin DC, Desmond AD.
Department of Human Anatomy, University of Liverpool, U.K.
The effect of the anti-oestrogen Tamoxifen on the seminal quality of 131 men was studied. Parameters studied before and after treatment were sperm density, total ejaculate count, percentage progressive motility, progressively motile ejaculate count, percentage total motility and total motile ejaculate count. In a group of 38 males, the effect on serum LH, FSH, testosterone, oestradiol and prolactin was also studied.
Tamoxifen significantly improved (p less than 0.05) the progressive motility in all patient groups where there was reduced pretreatment motility. Sperm density was also significantly improved in oligozoospermic patients. Elevations in the basal serum levels of FSH was noted, even in those patients where the basal level was elevated before treatment. Increases were also observed in the serum levels of the four other hormones studied.
Tamoxifen treatment in oligozoospermia.
Bartsch G, Scheiber K.
This study of the effects of long-term tamoxifen administration on semen analysis of oligospermic males confirms the potential therapeutic efficacy in normogonadotrophic oligospermia. 38 out of the 56 patients responded well to long-term treatment with 30 mg tamoxifen daily. According to the nomenclature of Eliasson,
32 patients reached normal sperm density and 16 patients normal sperm motility after tamoxifen treatment. In the group of responders a pregnancy rate of 34% is obtained. As far as the endocrinological parameters are concerned normogonadotrophic patients (responders and non-responders) showed an increase in testosterone, 17beta-estradiol, LH and FSH levels, whereas the levels of prolactin and testosterone/estradiol-binding globulin remained unchanged. No alterations at all were seen with regard to semen volume, during the time of tamoxifen treatment.
: Andrologia. 1980 Nov-Dec;12(6):546-8. Related Articles, Links
Tamoxifen treatment of oligozoospermia.
Schill WB, Landthaler M.
33 subfertile men with idiopathic normogonadotropic oligozoospermia were treated with the non-steroidal antiestrogen tamoxifen. A significant improvement of sperm count, total sperm output and sperm motility was observed.
I hope this answered your question efficiently. Peace...B32